Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

BCDA | BioCardia Inc.

Index- P/E- EPS (ttm)-0.68 Insider Own44.54% Shs Outstand20.08M Perf Week5.89%
Market Cap9.29M Forward P/E- EPS next Y-0.60 Insider Trans0.07% Shs Float11.99M Perf Month-47.44%
Income-13.01M PEG- EPS next Q-0.14 Inst Own15.28% Short Float / Ratio1.05% / 0.93 Perf Quarter-83.90%
Sales0.42M P/S22.13 EPS this Y7.96% Inst Trans-14.69% Short Interest0.13M Perf Half Y-77.84%
Book/sh0.08 P/B5.68 EPS next Y2.16% ROA-147.38% Target Price7.50 Perf Year-78.72%
Cash/sh0.20 P/C2.16 EPS next 5Y- ROE-310.91% 52W Range0.36 - 2.92 Perf YTD-79.43%
Dividend- P/FCF- EPS past 5Y25.25% ROI-469.17% 52W High-85.28% Beta1.27
Dividend %- Quick Ratio1.29 Sales past 5Y119.54% Gross Margin5.18% 52W Low19.38% ATR0.05
Employees36 Current Ratio1.29 Sales Q/Q-95.59% Oper. Margin-3068.24% RSI (14)26.15 Volatility4.54% 9.13%
OptionableYes Debt/Eq0.90 EPS Q/Q-18.73% Profit Margin-3061.18% Rel Volume0.17 Prev Close0.43
ShortableYes LT Debt/Eq0.70 EarningsAug 09 AMC Payout- Avg Volume135.27K Price0.43
Recom2.33 SMA20-7.61% SMA50-44.87% SMA200-76.09% Volume23,671 Change0.44%
Date Action Analyst Rating Change Price Target Change
Apr-16-21Downgrade Dawson James Buy → Neutral
Sep-06-23 10:31AM
Sep-05-23 07:15AM
Aug-11-23 09:29AM
Aug-09-23 06:05PM
04:05PM Loading…
Aug-02-23 07:00AM
Jul-24-23 07:00AM
Jul-10-23 08:11AM
Jul-05-23 07:00AM
Jun-20-23 05:14PM
Jun-08-23 07:00AM
May-28-23 08:08AM
May-23-23 07:00AM
May-12-23 06:06AM
05:45PM Loading…
May-10-23 05:45PM
May-09-23 07:00AM
May-03-23 08:00PM
Apr-28-23 07:00AM
Apr-04-23 07:00AM
Apr-01-23 12:47PM
Mar-31-23 06:05AM
Mar-29-23 08:15AM
Mar-16-23 07:00AM
Mar-06-23 01:06PM
Feb-01-23 06:30AM
Jan-31-23 05:39AM
Dec-22-22 07:00AM
05:07AM Loading…
Dec-21-22 05:07AM
Dec-15-22 07:00AM
Dec-06-22 07:00AM
Nov-09-22 05:35PM
Nov-02-22 05:31PM
Oct-03-22 01:33PM
Sep-14-22 07:00AM
Sep-09-22 07:00AM
Sep-08-22 07:00AM
Sep-06-22 11:03AM
Aug-31-22 07:00AM
Aug-24-22 09:40AM
Aug-10-22 05:15PM
Aug-04-22 02:04PM
Aug-01-22 08:00AM
Jul-12-22 08:15AM
Jun-15-22 08:00AM
May-11-22 05:55PM
May-06-22 03:15PM
May-04-22 08:30AM
Apr-13-22 10:25AM
Apr-12-22 07:15AM
Mar-30-22 03:51PM
Mar-29-22 04:05PM
Mar-24-22 08:00AM
Mar-22-22 08:30AM
Mar-01-22 08:00AM
Feb-14-22 07:30AM
Feb-03-22 02:53PM
Jan-10-22 08:00AM
Dec-15-21 08:00AM
Nov-10-21 04:30PM
Nov-08-21 04:30PM
Nov-02-21 03:02PM
Oct-21-21 07:30AM
Oct-12-21 08:00AM
Oct-07-21 08:00AM
Oct-06-21 08:00AM
Sep-28-21 06:46AM
Sep-10-21 08:00AM
Sep-09-21 04:32PM
Aug-16-21 08:30AM
Aug-13-21 08:00AM
Aug-12-21 10:05AM
Aug-05-21 03:00PM
Jul-15-21 08:00AM
Jun-23-21 08:00AM
Jun-22-21 08:00AM
Jun-21-21 08:00AM
Jun-18-21 10:48AM
Jun-14-21 08:00AM
Jun-02-21 08:00AM
May-13-21 12:11PM
Apr-26-21 08:00AM
Apr-01-21 01:52AM
Mar-30-21 09:15AM
Mar-15-21 08:00AM
Feb-23-21 08:00AM
Feb-17-21 08:30AM
BioCardia, Inc. is a clinical-stage biotherapeutic company. It engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Altman PeterPresident and CEOMay 26Buy1.606,2009,920469,239May 30 05:01 PM
FROST PHILLIP MD ET AL10% OwnerDec 16Buy1.68595,2381,000,0002,025,827Dec 20 08:15 PM
Altman PeterPresident and CEONov 11Buy1.861,4002,604332,947Nov 14 04:00 PM
Altman PeterPresident and CEONov 10Buy1.873,1005,797331,547Nov 14 04:00 PM
McClung DavidChief Financial OfficerOct 10Buy2.072,0004,14078,518Oct 11 07:01 AM